{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T02:38:14Z","timestamp":1789699094707,"version":"4.0.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T00:00:00Z","timestamp":1689379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T00:00:00Z","timestamp":1689379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Pulmonary fibrosis is a devastating disease, in which fibrotic tissue progressively replaces lung alveolar structure, resulting in chronic respiratory failure. Alveolar type II cells act as epithelial stem cells, being able to transdifferentiate into alveolar type I cells, which mediate gas exchange, thus contributing to lung homeostasis and repair after damage. Impaired epithelial transdifferentiation is emerging as a major pathogenetic mechanism driving both onset and progression of fibrosis in the lung. Here, we show that lung endothelial cells secrete angiocrine factors that regulate alveolar cell differentiation. Specifically, we build on our previous data on the anti-fibrotic microRNA-200c and identify the Vascular Endothelial Growth Factor receptor 1, also named\n                    <jats:italic>Flt1<\/jats:italic>\n                    , as its main functional target in endothelial cells. Endothelial-specific knockout of\n                    <jats:italic>Flt1<\/jats:italic>\n                    reproduces the anti-fibrotic effect of microRNA-200c against pulmonary fibrosis and results in the secretion of a pool of soluble factors and matrix components able to promote epithelial transdifferentiation in a paracrine manner. Collectively, these data indicate the existence of a complex endothelial-epithelial paracrine crosstalk in vitro and in vivo and position lung endothelial cells as a relevant therapeutic target in the fight against pulmonary fibrosis.\n                  <\/jats:p>","DOI":"10.1038\/s41419-023-05962-2","type":"journal-article","created":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T12:01:53Z","timestamp":1689422513000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Flt1 produced by lung endothelial cells impairs ATII cell transdifferentiation and repair in pulmonary fibrosis"],"prefix":"10.1038","volume":"14","author":[{"given":"Maria Concetta","family":"Volpe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Ciucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Zandomenego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5519-248X","authenticated-orcid":false,"given":"Roman","family":"Vuerich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6006-6544","authenticated-orcid":false,"given":"Nadja Anneliese Ruth","family":"Ring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Vodret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Salton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Marchesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Braga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Marcuzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossana","family":"Bussani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Colliva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvano","family":"Piazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Confalonieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6705-3076","authenticated-orcid":false,"given":"Serena","family":"Zacchigna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,15]]},"reference":[{"key":"5962_CR1","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/S2213-2600(20)30105-3","volume":"8","author":"Collaborators GBDCRD.","year":"2020","unstructured":"Collaborators GBDCRD. Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Respir Med. 2020;8:585\u201396.","journal-title":"Lancet Respir Med."},{"key":"5962_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-72607-1","volume":"10","author":"J Kang","year":"2020","unstructured":"Kang J, Han M, Song JW. Antifibrotic treatment improves clinical outcomes in patients with idiopathic pulmonary fibrosis: a propensity score matching analysis. Sci Rep. 2020;10:15620.","journal-title":"Sci Rep."},{"key":"5962_CR3","doi-asserted-by":"crossref","unstructured":"Fernandez Fabrellas E, Peris Sanchez R, Sabater Abad C, Juan Samper G. Prognosis and follow-up of idiopathic pulmonary fibrosis. Med Sci (Basel). 2018;6:51.","DOI":"10.3390\/medsci6020051"},{"key":"5962_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04439-4","volume":"13","author":"NAR Ring","year":"2021","unstructured":"Ring NAR, Volpe MC, Stepisnik T, Mamolo MG, Panov P, Kocev D, et al. Wet-dry-wet drug screen leads to the synthesis of TS1, a novel compound reversing lung fibrosis through inhibition of myofibroblast differentiation. Cell Death Dis. 2021;13:2.","journal-title":"Cell Death Dis"},{"key":"5962_CR5","doi-asserted-by":"crossref","unstructured":"Rehman M, Vodret S, Braga L, Guarnaccia C, Celsi F, Rossetti G, et al. High-throughput screening discovers antifibrotic properties of haloperidol by hindering myofibroblast activation. JCI Insight. 2019;4:e123987.","DOI":"10.1172\/jci.insight.123987"},{"key":"5962_CR6","doi-asserted-by":"publisher","first-page":"e86704","DOI":"10.1172\/jci.insight.86704","volume":"1","author":"RP Naikawadi","year":"2016","unstructured":"Naikawadi RP, Disayabutr S, Mallavia B, Donne ML, Green G, La JL, et al. Telomere dysfunction in alveolar epithelial cells causes lung remodeling and fibrosis. JCI Insight. 2016;1:e86704.","journal-title":"JCI Insight"},{"key":"5962_CR7","doi-asserted-by":"crossref","unstructured":"Parimon T, Yao C, Stripp BR, Noble PW, Chen P. Alveolar epithelial Type II cells as drivers of lung fibrosis in idiopathic pulmonary fibrosis. Int J Mol Sci. 2020;21:2269.","DOI":"10.3390\/ijms21072269"},{"key":"5962_CR8","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.cell.2011.10.003","volume":"147","author":"BS Ding","year":"2011","unstructured":"Ding BS, Nolan DJ, Guo P, Babazadeh AO, Cao Z, Rosenwaks Z, et al. Endothelial-derived angiocrine signals induce and sustain regenerative lung alveolarization. Cell 2011;147:539\u201353.","journal-title":"Cell"},{"key":"5962_CR9","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/nature17040","volume":"529","author":"S Rafii","year":"2016","unstructured":"Rafii S, Butler JM, Ding BS. Angiocrine functions of organ-specific endothelial cells. Nature 2016;529:316\u201325.","journal-title":"Nature"},{"key":"5962_CR10","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1016\/j.stemcr.2017.08.027","volume":"9","author":"XW Wang","year":"2017","unstructured":"Wang XW, Hao J, Guo WT, Liao LQ, Huang SY, Guo X, et al. A DGCR8-independent stable microRNA expression strategy reveals important functions of miR-290 and miR-183-182 families in mouse embryonic stem cells. Stem Cell Rep. 2017;9:1618\u201329.","journal-title":"Stem Cell Rep."},{"key":"5962_CR11","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1080\/01902148.2018.1455927","volume":"44","author":"C Miao","year":"2018","unstructured":"Miao C, Xiong Y, Zhang G, Chang J. MicroRNAs in idiopathic pulmonary fibrosis, new research progress and their pathophysiological implication. Exp Lung Res. 2018;44:178\u201390.","journal-title":"Exp Lung Res"},{"key":"5962_CR12","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/modpathol.2016.147","volume":"30","author":"M Chilosi","year":"2017","unstructured":"Chilosi M, Calio A, Rossi A, Gilioli E, Pedica F, Montagna L, et al. Epithelial to mesenchymal transition-related proteins ZEB1, beta-catenin, and beta-tubulin-III in idiopathic pulmonary fibrosis. Mod Pathol. 2017;30:26\u201338.","journal-title":"Mod Pathol"},{"key":"5962_CR13","doi-asserted-by":"publisher","first-page":"1804240","DOI":"10.1155\/2017\/1804240","volume":"2017","author":"L Fan","year":"2017","unstructured":"Fan L, Yu X, Huang Z, Zheng S, Zhou Y, Lv H, et al. Analysis of microarray-identified genes and microRNAs associated with idiopathic pulmonary fibrosis. Mediators Inflamm. 2017;2017:1804240.","journal-title":"Mediators Inflamm"},{"key":"5962_CR14","doi-asserted-by":"crossref","unstructured":"Moimas S, Salton F, Kosmider B, Ring N, Volpe MC, Bahmed K, et al. miR-200 family members reduce senescence and restore idiopathic pulmonary fibrosis type II alveolar epithelial cell transdifferentiation. ERJ Open Res. 2019;5:00138\u20132019.","DOI":"10.1183\/23120541.00138-2019"},{"key":"5962_CR15","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.ajpath.2011.10.005","volume":"180","author":"S Yang","year":"2012","unstructured":"Yang S, Banerjee S, de Freitas A, Sanders YY, Ding Q, Matalon S, et al. Participation of miR-200 in pulmonary fibrosis. Am J Pathol. 2012;180:484\u201393.","journal-title":"Am J Pathol"},{"key":"5962_CR16","doi-asserted-by":"publisher","first-page":"4008","DOI":"10.1172\/JCI99287","volume":"128","author":"SI Nureki","year":"2018","unstructured":"Nureki SI, Tomer Y, Venosa A, Katzen J, Russo SJ, Jamil S, et al. Expression of mutant Sftpc in murine alveolar epithelia drives spontaneous lung fibrosis. J Clin Invest. 2018;128:4008\u201324.","journal-title":"J Clin Invest"},{"key":"5962_CR17","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1093\/cvr\/cvaa012","volume":"117","author":"T Kocijan","year":"2021","unstructured":"Kocijan T, Rehman M, Colliva A, Groppa E, Leban M, Vodret S, et al. Genetic lineage tracing reveals poor angiogenic potential of cardiac endothelial cells. Cardiovasc Res. 2021;117:256\u201370.","journal-title":"Cardiovasc Res"},{"key":"5962_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-83723-x","volume":"11","author":"P Poggio","year":"2021","unstructured":"Poggio P, Songia P, Vavassori C, Ricci V, Banfi C, Barbieri SS, et al. Digital PCR for high sensitivity viral detection in false-negative SARS-CoV-2 patients. Sci Rep. 2021;11:4310.","journal-title":"Sci Rep."},{"key":"5962_CR19","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1158\/1541-7786.MCR-10-0497","volume":"9","author":"JD Roybal","year":"2011","unstructured":"Roybal JD, Zang Y, Ahn YH, Yang Y, Gibbons DL, Baird BN, et al. miR-200 inhibits lung adenocarcinoma cell invasion and metastasis by targeting Flt1\/VEGFR1. Mol Cancer Res. 2011;9:25\u201335.","journal-title":"Mol Cancer Res"},{"key":"5962_CR20","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/s42003-020-01404-3","volume":"3","author":"R Sestito","year":"2020","unstructured":"Sestito R, Cianfrocca R, Tocci P, Rosano L, Sacconi A, Blandino G, et al. Targeting endothelin 1 receptor-miR-200b\/c-ZEB1 circuitry blunts metastatic progression in ovarian cancer. Commun Biol. 2020;3:677.","journal-title":"Commun Biol"},{"key":"5962_CR21","doi-asserted-by":"publisher","first-page":"537929","DOI":"10.1155\/2009\/537929","volume":"2009","author":"KM Antoniou","year":"2009","unstructured":"Antoniou KM, Soufla G, Proklou A, Margaritopoulos G, Choulaki C, Lymbouridou R, et al. Different activity of the biological axis VEGF-Flt-1 (fms-like tyrosine kinase 1) and CXC chemokines between pulmonary sarcoidosis and idiopathic pulmonary fibrosis: a bronchoalveolar lavage study. Clin Dev Immunol. 2009;2009:537929.","journal-title":"Clin Dev Immunol"},{"key":"5962_CR22","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/s41586-020-2822-7","volume":"586","author":"A Gillich","year":"2020","unstructured":"Gillich A, Zhang F, Farmer CG, Travaglini KJ, Tan SY, Gu M, et al. Capillary cell-type specialization in the alveolus. Nature. 2020;586:785\u20139.","journal-title":"Nature."},{"key":"5962_CR23","doi-asserted-by":"publisher","first-page":"e90558","DOI":"10.1172\/jci.insight.90558","volume":"1","author":"Y Xu","year":"2016","unstructured":"Xu Y, Mizuno T, Sridharan A, Du Y, Guo M, Tang J, et al. Single-cell RNA sequencing identifies diverse roles of epithelial cells in idiopathic pulmonary fibrosis. JCI Insight. 2016;1:e90558.","journal-title":"JCI Insight"},{"key":"5962_CR24","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3389\/fmed.2017.00118","volume":"4","author":"J Tashiro","year":"2017","unstructured":"Tashiro J, Rubio GA, Limper AH, Williams K, Elliot SJ, Ninou I, et al. Exploring animal models that resemble idiopathic pulmonary fibrosis. Front Med (Lausanne). 2017;4:118.","journal-title":"Front Med (Lausanne)"},{"key":"5962_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3427","volume":"4","author":"CV Pecot","year":"2013","unstructured":"Pecot CV, Rupaimoole R, Yang D, Akbani R, Ivan C, Lu C, et al. Tumour angiogenesis regulation by the miR-200 family. Nat Commun. 2013;4:2427.","journal-title":"Nat Commun"},{"key":"5962_CR26","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s11658-019-0152-2","volume":"24","author":"Y Byun","year":"2019","unstructured":"Byun Y, Choi YC, Jeong Y, Lee G, Yoon S, Jeong Y, et al. MiR-200c downregulates HIF-1alpha and inhibits migration of lung cancer cells. Cell Mol Biol Lett. 2019;24:28.","journal-title":"Cell Mol Biol Lett"},{"key":"5962_CR27","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.21037\/tcr.2019.10.23","volume":"8","author":"SQ Wu","year":"2019","unstructured":"Wu SQ, He HQ, Kang Y, Xu R, Zhang L, Zhao XK, et al. MicroRNA-200c affects bladder cancer angiogenesis by regulating the Akt2\/mTOR\/HIF-1 axis. Transl Cancer Res. 2019;8:2713\u201324.","journal-title":"Transl Cancer Res"},{"key":"5962_CR28","doi-asserted-by":"publisher","first-page":"e920665","DOI":"10.12659\/MSM.920665","volume":"26","author":"H Yu","year":"2020","unstructured":"Yu H, Jiang X, Jiang L, Zhou H, Bao J, Zhu X, et al. Protocadherin 8 (PCDH8) inhibits proliferation, migration, invasion, and angiogenesis in esophageal squamous cell carcinoma. Med Sci Monit. 2020;26:e920665.","journal-title":"Med Sci Monit"},{"key":"5962_CR29","doi-asserted-by":"publisher","first-page":"318","DOI":"10.3389\/fbioe.2019.00318","volume":"7","author":"A Mammoto","year":"2019","unstructured":"Mammoto A, Mammoto T. Vascular niche in lung alveolar development, homeostasis, and regeneration. Front Bioeng Biotechnol. 2019;7:318.","journal-title":"Front Bioeng Biotechnol"},{"key":"5962_CR30","doi-asserted-by":"publisher","first-page":"109067","DOI":"10.1016\/j.biopha.2019.109067","volume":"117","author":"H Amano","year":"2019","unstructured":"Amano H, Mastui Y, Ito Y, Shibata Y, Betto T, Eshima K, et al. The role of vascular endothelial growth factor receptor 1 tyrosine kinase signaling in bleomycin-induced pulmonary fibrosis. Biomed Pharmacother. 2019;117:109067.","journal-title":"Biomed Pharmacother"},{"key":"5962_CR31","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/pmic.201500171","volume":"16","author":"YM Kulkarni","year":"2016","unstructured":"Kulkarni YM, Dutta S, Iyer AK, Venkatadri R, Kaushik V, Ramesh V, et al. A proteomics approach to identifying key protein targets involved in VEGF inhibitor mediated attenuation of bleomycin-induced pulmonary fibrosis. Proteomics. 2016;16:33\u201346.","journal-title":"Proteomics."},{"key":"5962_CR32","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s10753-013-9706-z","volume":"37","author":"E Bargagli","year":"2014","unstructured":"Bargagli E, Madioni C, Bianchi N, Refini RM, Cappelli R, Rottoli P. Serum analysis of coagulation factors in IPF and NSIP. Inflammation. 2014;37:10\u20136.","journal-title":"Inflammation."},{"key":"5962_CR33","doi-asserted-by":"crossref","unstructured":"Parimon T, Yao C, Habiel DM, Ge L, Bora SA, Brauer R, et al. Syndecan-1 promotes lung fibrosis by regulating epithelial reprogramming through extracellular vesicles. JCI Insight. 2019;4:e129359.","DOI":"10.1172\/jci.insight.129359"},{"key":"5962_CR34","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/bs.apcsb.2020.10.003","volume":"123","author":"S Mishra","year":"2021","unstructured":"Mishra S, Shah MI, Udhaya Kumar S, Thirumal Kumar D, Gopalakrishnan C, Al-Subaie AM, et al. Network analysis of transcriptomics data for the prediction and prioritization of membrane-associated biomarkers for idiopathic pulmonary fibrosis (IPF) by bioinformatics approach. Adv Protein Chem Struct Biol. 2021;123:241\u201373.","journal-title":"Adv Protein Chem Struct Biol"},{"key":"5962_CR35","doi-asserted-by":"publisher","first-page":"e0170741","DOI":"10.1371\/journal.pone.0170741","volume":"12","author":"R Niu","year":"2017","unstructured":"Niu R, Liu Y, Zhang Y, Zhang Y, Wang H, Wang Y, et al. iTRAQ-based proteomics reveals novel biomarkers for idiopathic pulmonary fibrosis. PLoS One. 2017;12:e0170741.","journal-title":"PLoS One"},{"key":"5962_CR36","doi-asserted-by":"publisher","first-page":"100524","DOI":"10.1016\/j.mcpro.2023.100524","volume":"22","author":"L Wang","year":"2023","unstructured":"Wang L, Zhu M, Li Y, Yan P, Li Z, Chen X, et al. Serum proteomics identifies biomarkers associated with the pathogenesis of idiopathic pulmonary fibrosis. Mol Cell Proteom. 2023;22:100524.","journal-title":"Mol Cell Proteom"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-023-05962-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-023-05962-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-023-05962-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T12:02:09Z","timestamp":1689422529000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-023-05962-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,15]]},"references-count":36,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["5962"],"URL":"https:\/\/doi.org\/10.1038\/s41419-023-05962-2","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,15]]},"assertion":[{"value":"5 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Human lung tissue from unidentified patients with IPF or recently deceased donors was obtained from the Lung Tissue Bank at Temple Lung Center (Dept of Thoracic Medicine and Surgery, Temple University, Philadelphia, PA, USA). ATII cells were isolated after obtaining written informed consent by patients and approval by the Institutional Review Board (approval 4407) at Partners Healthcare and Temple University. Animal experiments were conducted in compliance with European guidelines and international laws and policies, with ethical approvals by ICGEB Animal Welfare Board, Ethical Committee, and Italian Ministry of Health (authorizations 538\/2019 and 648\/2019).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"437"}}